Despite all his new ventures, I still find it hard to believe that Jonnie would just give up on anatabine. Maybe he was the second bidder that the counsel Linda told me about that dropped out. Maybe he had some connection to Hydrapharm, but I think he'd know he was violating patent law. But all just speculation. But I bet if he could have the anatabine IP for $500, he woulnd't turn it down.
News 
Market Data 
Discover 
